Serotonin (5-HT) is an indirect modulator of the electric organ discharge (EOD) in the weakly electric gymnotiform fish, Brachyhypopomus pinnicaudatus. Injections of 5-HT enhance EOD waveform "masculinity", increasing both waveform amplitude and the duration of the second phase. This study investigated the pharmacological identity of 5-HT receptors that regulate the electric waveform and their effects on EOD amplitude and duration. We present evidence that two sets of serotonin receptors modulate the EOD in opposite directions. We found that the 5HT 1A R agonist 8-OH-DPAT diminishes EOD duration and amplitude while the 5HT 1A R antagonist WAY100635 increases these parameters. In contrast, the 5HT 2 R agonist α-Me-5-HT increases EOD amplitude but not duration, yet 5-HT-induced increases in EOD duration can be inhibited by blocking 5HT 2A/2C -like receptors with ketanserin. These results show that 5-HT exerts bi-directional control of EOD modulations in B. pinnicaudatus via action at receptors similar to mammalian 5HT 1A and 5HT 2 receptors. The discordant amplitude and duration response suggests separate mechanisms for modulating these waveform parameters.
Serotonin (5-HT) is a neuromodulator so ubiquitous that hardly any physiological function or behavior is free from its direct or indirect effects. As a result, a full account of neuroendocrine control of behavior requires a thorough assessment of 5-HT's function across a wide range of circumstances, even as the pervasive presence of 5-HT in the nervous system complicates unambiguous assessment of its functions. Particularly, serotonin is involved in the regulation of diametrically opposed behaviors, aggression and subordinance (Summers and Winberg, 2006) . Serotonin activity rises in both dominant and subordinate males but rapidly returns to baseline in dominants while it stays chronically high in subordinates (Overli et al., 1999; Summers and Winberg, 2006) . Prior social defeat or success during aggressive interactions affects future aggressive behaviors and the activity of the serotonergic system (Winberg et al., 1992; Winberg et al., 1997b) . Furthermore, social experience affects the regulatory effect of serotonin on dominant behaviors via serotonin receptors 1A and 2A (Yeh et al., 1996) .
Pharmaceutical 5HT 1A agonists inhibit aggression or induce submissive behaviors in a wide range of non-mammalian vertebrates including green anoles (Deckel and Fuqua, 1998) , Arctic charr (Hoglund et al., 2002; Winberg and Nilsson, 1993) , rainbow trout (Winberg et al., 1997a) , and sticklebacks (Bell et al., 2007) . In addition, 5HT 1A receptors operate as both postsynaptic receptors and as pre-synaptic autoreceptors to either suppress or stimulate stress responses in teleosts as they do in mammals (Hoglund et al., 2002) . Despite the functionally and anatomically conserved nature of the serotonin system in vertebrates (Parent et al., 1984) and the abundance of data indicating a role for 5HT 1A receptors in regulating social behaviors in fish, nothing is known about the function of 5HT 2 -like receptors in teleosts (Bagdy, 1996; Eison and Mullins, 1996) . The complexity of the 5-HT receptor system and the multiple levels upon which serotonin influences physiology and Available online at www.sciencedirect.com Hormones and Behavior 53 (2008) 481 -488 www.elsevier.com/locate/yhbeh behavior hints at a system capable of producing contextually appropriate responses to a wide range of stimuli using the same structures, circuits, and ligands. Gymnotiform fish are excellent models to evaluate the processes underlying the connection between environmental stimuli, motivational state and behavioral output. These fish emit an easily-quantifiable electric signal generated by a wellmapped neural motor network. Male-male interactions alter these electric signals. Furthermore, the electrocommunication network of these fish is dynamic, and is modulated by hormones, modulators, and neurotransmitters. Thus, changes in the electric signal of males during aggressive interactions give us a real-time broadcast of the neuromodulatory regulation of the electrocommunication signals of competing males.
The electric organ discharge (EOD) of weakly electric gymnotiform fish is a dual-purpose signal used to navigate and communicate in total darkness. The EOD pulse of Brachyhypopomus pinnicaudatus is a biphasic sinusoidal wave that increases or decreases in amplitude and in the duration of the second phase (Fig. 1) . The EOD is produced by electrocytesspecialized excitable cells in the peripheral electric organ. Social encounters and environmental stimuli modulate the EOD waveform by altering the membrane biophysics and discharge waveforms of individual electrocytes (Ferrari et al., 1995; McAnelly and Zakon, 2000; Mills and Zakon, 1991) , resulting in either a larger or smaller waveform. Social encounters modulate the EOD within minutes and large waveforms and/or rapid enhancements are associated with dominance status (Franchina et al., 2001; Hagedorn and Zelick, 1989; Stoddard et al., 2003) .
We have shown that intramuscular injections of 5-HT cause male B. pinnicaudatus to increase their EOD amplitude and duration akin to the waveform changes observed during malemale social interactions (Stoddard et al., 2003) . These effects of 5-HT do not result from its direct action on the electrocytes, whereas melanocortin peptides do modulate the discharge waveforms of single electrocytes directly (Markham and Stoddard, 2005) . Thus, it is possible that 5-HT modulates EOD waveform by acting centrally to elicit release of melanocortins into circulation.
Therefore we sought to clarify the proximate mechanisms of serotonin's action on EOD modulations in B. pinnicaudatus.
The 5-HT system consists of extensive projections of serotonergic neurons throughout the brain and a labyrinthine system of serotonin receptors. Seven distinct 5-HT receptor families (5HT 1 R-5HT 7 R) have been identified and some families possess multiple receptor subtypes (e.g., 5HT 2A , 2B , 2C ) (Glennon et al., 2000) . Stimulating (or blocking) different serotonin receptor types often results in opposite actions on target tissues (Welch et al., 1993) . The seemingly incongruous role of the same agonist as activator and inhibitor can be explained by evidence that different serotonin receptor types activate different serotonergic signaling pathways, each of which produces different results downstream (Jorgensen et al., 1998; Saphier et al., 1995; Welch et al., 1993) . Studies have confirmed that 5-HT receptors with pharmacological profiles similar to mammalian 5HT 1 and 5HT 2 -like receptors are present in teleosts, and at least three different 5-HT receptor types have been localized in whole teleost brain homogenates (Dietl and Palacios, 1988; McDonald and Walsh, 2004; Winberg and Nilsson, 1996; Yamaguchi and Brenner, 1997) .
Our objective in this study was to clarify our understanding of serotonergic regulation of weakly electric social signals and to identify which 5-HT receptor types were pharmacologically linked to changes in EOD. We used various serotonergic compounds to assess activity and directionality of EOD modulations in response to activating or inhibiting specific 5-HT receptor types. We found that the opposing actions of two serotonin receptors showing pharmacology characteristic of the mammalian 5HT 1A R and 5HT 2 R regulate the EOD waveform.
Methods

Animals
Sexually mature male B. pinnicaudatus (Hopkins, 1991) , bred and maintained on Florida International University campus, were randomly collected from outdoor breeding pools throughout 2002-2006 and brought indoors for pharmacological challenge tests (n = 4-12 males per trial). Fish were weighed and measured prior to placement in separate recording tanks to calculate appropriate injection doses and then left undisturbed for a minimum of 24-h before pharmacological challenges were administered to allow individuals to acclimate to their tanks and to measure baseline EODs.
All methods used in these experiments were approved in advance by the FIU IACUC and complied with the "Principles of Animal Care" publication No. 86-23, revised 1985, of the National Institutes of Health.
Electric signal recording
We recorded EODs with an automated, calibrated recording system previously described in detail (Stoddard et al., 2003) . The system automatically records EODs when the fish passes through or rests in the geometric center of the tank. EODs are collected approximately once a minute around the clock throughout the duration of each experiment. We measured amplitude of the EOD waveform peak-to-peak, and duration of the second phase as τ P2 , the time constant of an inverse exponential function fit to the decay segment of the second phase (P2) of the EOD waveform (Fig. 1 ). Table 1 shows reported mammalian 5-HT receptor affinities of the serotonergic drugs that we used to characterize the mechanisms of 5-HT activity. Fig. 1 . Measure of Brachyhypopomus pinnicaudatus EOD waveform parameters. Amplitude was measured peak-to-peak for the whole waveform. The time constant of repolarization of the 2nd phase, τ P2 , was estimated by fitting an inverse exponential function fit to the decay segment.
Chemicals and reagents
Alpha-methyl-5-hydroxytryptamine (α-Me-5-HT, 5HT 2 agonist), 8-hydroxy-din-propylamino tetralin (8-OH-DPAT, 5HT 1A and 5HT 7 agonist), and 6-chloro-2-(1-piperazinyl) pyrazine (MK212, 5HT 2 agonist) were purchased from Tocris
, 2,5-dimethoxy-4-iodoamphetamine (DOI, 5HT 2 agonist), and ketanserin tartrate salt (ketanserin, 5HT 2A/2C antagonist) were purchased from Sigma-Aldrich (St. Louis, MO, US). Ketanserin was dissolved at pH 6.7, titrated to pH 7.2 with NaOH, and diluted to a final concentration of 2.5 mM. Other pharmacological compounds were dissolved in physiological saline as described previously (Stoddard et al., 2003) .
Pharmacological challenges
We found previously that EOD response to intramuscular injections of 5-HT saturates at 2.5 nM g − 1 body weight (bw). We used this concentration as the starting point to select doses for serotonergic drugs, but if we obtained either no effect or an equivocal effect we performed additional injections at higher and lower doses (Fig. 2) . We had little choice but to inject the drugs peripherally. Central injection can only be done on cannulated or anesthetized fish, and the fish are too small for cannulation. Every anesthetic tested increases the EOD waveform parameters (M. Markham unpubl. data). Thus we chose intramuscular injection, which had proven to be successful with serotonin (Stoddard et al., 2003) . We prepared the injection solutions to produce the desired dose when injected intramuscularly at 1 μl g − 1 body weight. Saline injections (1 μl g − 1 bw) served as a control condition for effects of handling and injection. All injections were given midday (10:00-15:00) and EOD recording resumed immediately after fish were returned to the tank. Handling time from capture, through injection, to replacement in the tank was less than one minute, and produced little change in EOD waveform (Stoddard et al., 2003) .
To probe for central regulation of the EOD by the 5HT 2 R family, we used three partially selective agonists: MK212 [30 mM], DOI [0.25 and 2.5 mM], and α-Me-5-HT [0.25, 2.5, 12.5, and 25 mM]. While each of these agonists has high affinity for 5HT 2 receptors and differentiates well against other 5-HT receptor families, they do not exhibit reliable selectivity between the three receptor subtypes in this family: 5HT 2A , 2B , and 2C (Baxter et al., 1995; Hoyer et al., 2002; Jerman et al., 2001; Ramage, 2005; Van de Kar et al., 2001) . Modulations of the EOD in response to one or more of these ligands would therefore support involvement of at least one 5HT 2 receptor type; however such a response would not exclude involvement of the other subtypes in regulating the EOD.
The silent antagonist (i.e., ligand with no intrinsic effect) ketanserin is more useful for distinguishing which of the 5HT 2 receptor subtypes may be exerting an effect. Ketanserin, unlike 5HT 2 R agonists, is highly selective for the 5HT 2A/2C R over the 5HT 2B R (Table 1) . We found that ketanserin alone neither increased nor decreased the EOD waveform, suggesting that given alone it does not influence or interfere with normal EOD modulations. We therefore conducted serial challenges to determine whether ketanserin could block the effects of a successive 5-HT injection. We pre-treated a control group of fish with saline and the test group with ketanserin [2.5 mM]. Fish in both groups were then given a second injection of 5-HT [2.5 mM] 15-45 min later and any changes in their EOD waveforms were recorded.
To probe for waveform regulation by the 5HT 1A R, we capitalized on ligands highly selective for that receptor in a broad array of taxa: the agonist 8-OH-DPAT [0.025, 0.25, and 2.5 mM] and the antagonist WAY100635 [0.025, 0.25, and 2.5 mM]. We also sought to explore whether there were any interactions between the 5HT 1A and the 5HT 2 receptors in the regulation of EOD waveform. To test the hypothesis that the 5HT 1A R and the 5HT 2 R are consecutively aligned within the same neural pathway, we sought to enhance the EOD through the 5HT 1A R after blocking the 5HT 2 R. Thus we pre-treated males with ketanserin [2.5 mM] followed 15-45 min later by WAY100635 [2.5 mM]. Control treatment consisted of saline pre-treatment followed by WAY100635.
Data analysis
Changes in the EOD waveform resulting from our pharmacological challenge trials are superimposed upon circadian cycles in waveform parameters (Franchina and Stoddard, 1998; Stoddard et al., 2003) . We therefore mathematically isolated challenge-induced changes in these measures by subtracting the circadian oscillation as reported previously (Stoddard et al., 2003) . This analysis allowed us to measure changes in EOD amplitude and τ P2 caused by the pharmacological challenges, apart from normal circadian modulations in the EOD. Additionally, our earlier work showed that responses to 5-HT challenge are closely related to an individual's baseline values of EOD amplitude and τ P2 (Stoddard et al., 2003) . These parameters vary considerably between individuals; therefore, we quantified individual challenge responses as the proportion change relative to that individual's EOD baseline on the day of that challenge: [(peak value after injection − baseline value) / baseline value].
We analyzed amplitude and τ P2 responses to single-injection serotonergic challenges using separate omnibus one-way ANOVA with significance level set at p ≤ 0.05. We then conducted post-hoc analysis using Dunnett's pairwise multiple comparison t-test to compare responses to each challenge against responses to a single control (saline injection) (Dunnett, 1955 (Dunnett, , 1964 . We compared test statistics to two-tailed critical values because we had no a priori expectation for directionality of effect of each drug on EOD.
Responses to ketanserin + 5-HT and ketanserin + WAY100635 challenges were analyzed using two-sample Student's t-tests assuming unequal variances. We compared the calculated test statistic to values from a one-tailed critical region because we anticipated that ketanserin would either have no effect on or block EOD response. Data analysis was generated using MATLAB v7.1 and SPSS 15.0. Data are reported in figures as mean ± 95% confidence intervals and significance values from Dunnett's t-test are reported in Table 2 .
Results
The one-way ANOVAs for both amplitude and τ P2 responses to single-injection serotonergic challenges showed that some challenge responses were significantly different ( p b 0.001 for Table 1 Receptor affinities (pK i s) for serotonergic agents used in this study, based on mammalian studies 5HT 1A R 5HT 2A R 5HT 2B R 5HT 2C R 5HT 7 R 5-HT 8.8 (Peroutka and Howell, 1994) 8.2 (Peroutka and Howell, 1994) 7.6 (Peroutka and Howell, 1994) 8.0 (Peroutka and Howell, 1994) 8.7-9.2 (Ruat et al., 1993; Shen et al., 1993) 
9.2 (Millan et al., 1992) 5.2 (Millan et al., 1992) b5 (Millan et al., 1992) 7.7 (Sleight et al., 1995) DOI (5HT 2 agonist) 5.2 (van Wijngaarden et al., 1990) 7.6 (Schechter and Simansky, 1988) 7.0 (Schechter and Simansky, 1988) MK212 (5HT 2 agonist) 5.3 (Smythe et al., 1988) 4.8 (Smythe et al., 1988) 6.2 (Hoyer et al., 1994) 6.2 (Smythe et al., 1988 ) WAY100635 (5HT 1A antagonist) 8.9 (Fletcher et al., 1996) b7 (Fletcher et al., 1996) b7 (Fletcher et al., 1996) Ketanserin (5HT 2A/2C antagonist) 5.9 (Hoyer, 1989) 8.7 (Schreiber et al., 1995) 5.4 (Hoyer et al., 1994) 7.2 (Schreiber et al., 1995) α-Me-5-HT (5HT 2 agonist) 6.1 (Baxter et al., 1995) 8.4 (Baxter et al., 1995) 6.2 (Baxter et al., 1995) both amplitude and τ P2 ). We report the results from Dunnett's multiple comparison t-tests below.
Effect of 5HT 2 R selective ligands on EOD waveform
Of the three 5HT 2 R agonists tested, only the lowest concentration of α-Me-5-HT [0.25 mM] increased the EOD amplitude response (Dunnett's t-test; p = 0.016). No 5HT 2 R agonist had an effect on τ P2 at any dose (Fig. 2) . The EOD response to one 5HT 2 R agonist implicates the involvement of a receptor in the 5HT 2 R family in EOD waveform modulation.
The 5HT 2A/2C R silent antagonist ketanserin had no effect on its own (data not shown), as expected for a silent antagonist, but blocked the typical 5-HT enhancement of EOD τ P2 (Fig. 3a) . Fish pre-treated with ketanserin showed little or no increase in τ P2 in response to the 5-HT injection, compared to fish pretreated with saline which increase τ P2 following injection with 5-HT (two-sample t-test; p = 0.02). Fish pre-treated with ketanserin exhibited amplitude responses similar to fish receiving saline pre-treatment (two-sample t-test; p = 0.26) (Fig. 3b) .
Effect of 5HT 1A R selective ligands on EOD waveform
Each of the three doses of the highly selective 5HT 1A R agonist 8-OH-DPAT reduced both amplitude and τ P2 relative to controls (Dunnett's t-test; p b 0.01), with the exception of amplitude response at the middle dose [0.25 mM] (Dunnett's t-test; p = 1.0) (Fig. 2) . Treatment with the ostensibly silent 5HT 1A R antagonist WAY100635 resulted in enhancement of both amplitude and τ P2 at the highest dose tested [2.5 mM] (Dunnett's t-test; p b 0.001). In the serial challenges designed to explore possible interactions between 5HT 1A and 5HT 2 receptors, we found that the saline + WAY100635 group showed the expected increases in the amplitude response to WAY100635 and fish that received ketanserin + WAY100635 exhibited similar increases (two-sample t-test, p = 0.42), showing that blocking the Responses presented as thick black lines and solid black circles represent challenge responses that were significantly different ( p b 0.05) than responses to saline control determined by Dunnett's t-test. Injections of 5HT 2 receptor-specific agents differentially modulate the EOD waveform. Injections of MK212 or DOI had no effect on either amplitude or τ P2, while injections of α-Me-5-HT enhanced EOD amplitude, but not τ P2 . 5HT 1A receptor-specific agents modulated EOD waveform in opposite directions. The low and high dose of the 5HT 1A agonist 8-OH-DPAT inhibited amplitude, while all three doses inhibited τ P2 response to challenge. Conversely, the highest dose of the 5HT 1A R antagonist, WAY100635, enhanced both amplitude and τ P2 .
5HT 2A/2C receptors has no effect on the EOD amplitude response to 5HT 1A antagonism (Fig. 3b) . Quite the opposite, and not expected, τ P2 response was significantly higher following ketanserin + WAY100635 than following saline + WAY100635 challenge (two-sample t-test; p = 0.02) (Fig. 3a) .
Discussion
Our results suggest that two families of serotonin receptors are involved in regulating changes in EOD waveform. We found that serotonin receptors pharmacologically similar to mammalian 5HT 2 and 5HT 1A receptors are capable of producing EOD waveform modulations and that these receptors modulate the EOD waveform in different ways. We also found that EOD τ P2 was more responsive to some serotonergic agents than EOD amplitude in general, which was unexpected given that both parameters can be enhanced by 5-HT (Stoddard et al., 2003) . Perhaps, EOD amplitude and τ P2 are differentially regulated by parallel neuroendocrine pathways. 5HT 1A -like and possibly 5HT 2 -like receptors have been localized in Arctic charr brain homogenate (Winberg and Nilsson, 1996) ; at the same time distributions of 5-HT receptors in the teleost brain are still unknown. We propose this model as a guide for future research investigating the placement, distribution, and molecular identity of these different 5-HT receptors in weakly electric fish brains. Currently, the specific location(s) and distribution of 5-HT receptors in the brains of electric fish are not known; however, our results provide a blueprint for which 5-HT receptors to target first in future receptor localization experiments.
The 5HT 1A receptor agonist 8-OH-DPAT reduced EOD amplitude and τ P2 while the 5HT 1A antagonist WAY100635 lead to increased waveforms. The silent 5HT 1A R antagonist WAY100635 should have no intrinsic effect on its own, yet both waveform parameters increased in response to this challenge. These results signify that: (1) a 5HT 1A R-like receptor is present and pharmacologically relevant in this species and, (2) endogenous release of 5-HT tonically suppresses EOD enhancement via 5HT 1A receptors in this circuit and blocking these receptors with WAY100635 releases this inhibition.
Recent evidence has shown that WAY100635 is a "potent" dopamine receptor agonist as well as a 5HT 1A antagonist, possibly obfuscating interpretation of our results (Chemel et al., 2006) . To dispel this ambiguity, we injected fish with dopamine [25 mM] and saw a depression of EOD waveform parameters (data not shown). If the increased EOD responses to WAY100635 challenge were the result of actions at dopamine receptors, we would have expected responses to WAY100635 and dopamine to be in the same direction. Consequently, we doubt that the results of our WAY100635 injections reflect any known activity at a dopamine receptor. While our 5HT 1A agonist/antagonist challenges clearly support our assertion that this receptor type is present and relevant to regulation of the EOD, differences in responses to different doses of these ligands suggest the role of the 5HT 1A R may be more complex in our fish than tonic inhibition of melanocortin release.
The 5HT 1A R antagonist WAY100635 enhanced both EOD parameters only at the highest dose tested, whereas 8-OH-DPAT inhibited both parameters (except at the middle dose [0.25 mM]). The lack of response at the two lower doses of WAY100635 might be explained by 5HT 1A receptors possessing greater affinity for agonists than antagonists (Gozlan et al., 1983) or the possibility that this ligand is competing with tonic levels of 5-HT present at the 5HT 1A R. An explanation for the irregular response pattern we observed due to 8-OH-DPAT challenge, however, is not as straightforward.
In vertebrates, including teleosts, the 5HT 1A R operates both as a somatodendritic autoreceptor on serotonergic neurons and as a post-synaptic receptor on cells receiving projections from 5-HT neurons (Gozlan et al., 1983; Hoglund et al., 2002) . Autoreceptor activation leads to reduced neuronal firing and Fig. 3 . Injecting fish with the 5HT 2A receptor silent antagonist ketanserin blocked the 5-HT-typical EOD enhancement in τ P2 (a) but had no effect on amplitude response to 5-HT injection (b). Pre-treating fish with ketanserin followed by 5HT 1A antagonist, WAY100635, does not block enhancement of τ P2 , rather the ketanserin + WAY100635 response is greater than response to WAY100635 alone (a). Amplitude responses to challenge with ketanserin + WAY100635 were no different than responses to WAY100635 given alone (b). Responses were measured relative to individual baseline [(peak − baseline) / baseline] and error bars represent mean ± 95% confidence intervals of combined data. A solid black circle denotes statistically significant differences ( p b 0.05) between responses to ketanserin pre-treatment and saline pre-treatment challenge responses as determined by one-tailed Student's t-test.
thus reduced 5-HT activity in the brain (Invernizzi et al., 1991; Sharp et al., 1989; VanderMaelen et al., 1986 ) whereas postsynaptic 5HT 1A activation mediates behavioral effects of brain 5-HT (Carey et al., 2005; Rabiner et al., 2004) . Half of the fish that were given 8-OH-DPAT at [0.25 mM] enhanced their amplitudes and the other half in this group reduced theirs after injection, raising the possibility that both types of 5HT 1A receptor are operational within this system. If this was so, higher density or activity of post-synaptic 5HT 1A receptors might have been present in those fish for which 8-OH-DPAT increased EOD amplitude, subsequently overriding the inhibitory effect of 8-OH-DPAT on 5HT 1A autoreceptors. Another hypothesis, not incompatible with this one, is that multiple serotonergic pathways bearing different combinations of receptors drive EOD parameters in different directions.
Not all drugs we used cross the blood-brain barrier to the same extent. For instance 5HT 2 R agonists readily penetrate the blood-brain barrier while 5HT 2 R antagonists like ketanserin do not (Michiels et al., 1988) . Indeed, ketanserin acts on 5HT 2 receptors to block the passage of 5-HT through the blood-brain barrier (Sharma et al., 1995) . Thus ketanserin could block 5-HT action on the EOD by preventing its passage into the brain. Alternately our ketanserin results are consistent with a 5HT 2A R expressed in the pituitary or circumventricular organs of hypothalamus, which are not protected by the blood-brain barrier. The results of our dual-injection experiments with ketanserin + WAY100635 provide evidence to support this second hypothesis. While ketanserin blocked the EOD τ P2 enhancing effect of 5-HT, it significantly augmented the increase produced by 5HT 1A R antagonist WAY100635. WAY100635 passes readily through the blood-brain barrier (Farde et al., 1998) , so ketanserin's action would appear to be on a 5HT 2A R in the brain itself, perhaps in a pathway that inhibits the pathway expressing the 5HT 1A R.
Activation of 5HT 2 -like receptors with α-Me-5-HT increased EOD amplitude with no significant effect on EOD τ P2 . Since α-Me-5-HT has a slightly higher affinity for the 5HT 2B receptor than for either the 5HT 2A/2C , and because we observed a response at the lowest rather than the highest dose, our agonist challenges suggest the 5HT 2B -like receptor has a role in modulating EOD amplitude. However, ketanserin, the antagonist highly selective for the 5HT 2A/2C receptor, blocked EOD response to 5-HT. Given the high selectivity of ketanserin for the 5HT 2A/2C receptor, the ketanserin block of 5-HT-induced EOD waveform modulations is strong evidence that 5-HT acts specifically via a 5HT 2A/2C -like receptor to modulate EOD τ P2 . While these challenges do not definitively identify which 5HT 2 -like receptor(s) might be involved in modulating the EOD, they do reveal that the direction of action of a 5HT 2 -like receptor is to increase EOD amplitude and τ P2 , opposing the action of a 5HT 1A -like receptor.
Our original goal was to clarify mechanisms of 5-HT regulation of the EOD within a social communication context where we assumed that EOD modulations reflect social dominance and subordinance. Recent research conflicts with the prevailing view that 5-HT activity necessarily suppresses aggressive behavior. High 5-HT turnover in parts of the brain has been found in aggressive and dominant individuals (Korzan et al., 2000; Matter et al., 1998) and a "primed" serotonergic system may be necessary to enable an individual to produce an appropriate behavioral response in a complex social context (Sperry et al., 2005) . These findings would help explain the apparent paradox we observed in our fish wherein 5-HT injections further masculinized the males' EODs (Stoddard et al., 2003) . If the classical account of the serotonin system as an inhibitor of aggression is accurate and enhancements of the EOD in the presence of conspecifics are aggressive, then the reduction in EOD parameters following activation of the 5HT 1A R makes perfect sense, but the increase in these parameters following activation of the 5HT 2 R is unexpected. Perhaps both very low and very high levels of serotonergic activity augment the EOD, allowing fish to increase the potency of their communication signal both when dominant (low 5-HT enhances the EOD via the 5HT 1A R) and when newly challenged (high 5-HT enhances the EOD via a 5HT 2 R).
If aggression is inhibited by the 5HT 1A R, as some studies suggest (Joppa et al., 1997; Sanchez, 1997; Simon et al., 1998; Sperry et al., 2005) , then this receptor type may reside in a circuit that rapidly inhibits enhanced EOD response in weakly electric fish, perhaps after a social encounter terminates or in response to confrontation with a more dominant individual. Activating the 5HT 1A R autoreceptor inhibits neuronal firing and decreases 5-HT synthesis (Perreault et al., 2003; Sperry et al., 2005) . Our data show that activating 5HT 1A R with 8-OH-DPAT causes a dampening of both EOD parameters, although we have not yet determined the detailed social significance of specific patterns of enhancements and reductions in the EOD waveform. We expect to find that the social significance of a rise or fall in EOD waveform parameters is more complicated than linear social rank.
Modulations in the EOD, particularly enhancements of τ P2 , have been proposed to function as mate attracting signals (Hopkins, 1972 (Hopkins, , 1974a . The enhancements seen from serotonergic pathways commonly involved in regulation of aggression and dominance behavior are consistent with a role in intrasexual competition as well. Differential regulation of amplitude and τ P2 suggests that the EOD is a multicomponent signal that conveys different information such as body condition and motivation to male or female receivers. Because the expression of EOD parameters are intricately tied to each other, it would be easy to see how the mechanisms that control one social signal, e.g., aggression, could be co-opted to regulate another social signal, e.g., mate attraction.
Melanocortins modulate both EOD amplitude and τ P2 by direct action on electrocytes (Markham and Stoddard, 2005) , and ongoing experiments indicate that melanocortins are both necessary and sufficient for short-term modulation of these parameters. Thus, the variability in response of amplitude and τ P2 between serotonergic drugs and between sets of trials is hard to explain. Our current understanding does not account for how α-Me-5-HT might increase amplitude without increasing τ P2 . Nor do we understand why our first injection trials with 5-HT (Stoddard et al., 2003) and with WAY100635 (Fig. 2) increased both EOD amplitude and τ P2 whereas the second sets (Fig. 3) increased only τ P2 . Neither seasonal nor maturational differences can explain these differences, leading us to suspect that particular social environments in our outdoor breeding pools may somehow affect responsiveness of these parameters through the actions of steroids or other neuromodulators.
